Hyperglycemia
Conditions
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects giving written informed consent 2. Healthy men and women of 35 to 74 years age and whose fasted blood glucose levels were 110 mg/dl to 126 mg/dl at the screening period
Exclusion criteria
Exclusion criteria: 1. Subjects in the drug therapy or in the hospital care 2. Sever systemic diseases affecting the results of this study 3. Subjects with an immunodeficiency 4. Subjects with a previous history or merger of malignant tumors 5. Subjects in pregnancy or in nursing 6. Subjects with a habit of intake more than twice in a week of fermented milk or lactic fermenting beverage in three months before screening test 7. Constant use of oral medication or supplements affecting glucese or lipid matabolism in three months before screening test 8. Subjects with food allergy or medicine allergy 9. Subjects who drink a lot of alcohol 10. Subjects who participated in other clinical trials within one month before the agreement of participants in this study 11. Subjects who are judged as unsuitable for the study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasted blood glucose level Glycoalbumin Insulin resistance index | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood fat level Body fat percentage Blood inflammatory cytokines | — |
Countries
Japan
Contacts
Public ContactMasao Matsuoka
HUMA R&D CORP Clinical Depelopment Division
Outcome results
None listed